REGISTERED NUMBER: 03237171 (England and Wales)

B10 MED PROPERTIES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2025

Page

Company Information

1

Abridged Balance Sheet

2

to

3

Notes to the Financial Statements

4

to

6

DIRECTORS:

Mr J D Hayton

Mrs D J Hayton

SECRETARY:

Mrs D J Hayton

REGISTERED OFFICE:

Heritage House

Murton Way

Osbaldwick

York

North Yorkshire

YO19 5UW

REGISTERED NUMBER:

03237171 (England and Wales)

ACCOUNTANTS:

UHY Calvert Smith

Chartered Accountants

Heritage House

Murton Way

Osbaldwick

York

North Yorkshire

YO19 5UW

FIXED ASSETS

Tangible assets

4

-

-

Investments

5

331,020

134,295

331,020

134,295

CURRENT ASSETS

Debtors

655,331

541,936

Cash at bank

197,533

614,676

852,864

1,156,612

CREDITORS

Amounts falling due within one year

31,818

139,135

NET CURRENT ASSETS

821,046

1,017,477

TOTAL ASSETS LESS CURRENT LIABILITIES

1,152,066

1,151,772

CAPITAL AND RESERVES

Called up share capital

120

120

Retained earnings

1,151,946

1,151,652

SHAREHOLDERS' FUNDS

1,152,066

1,151,772

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 August 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2026 and were signed on its behalf by:

Mrs D J Hayton - Director

1.	STATUTORY INFORMATION

B10 Med Properties Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover represents the income derived from a managed investment portfolio, but there was none in the year under review.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Equipment, fixtures & fittings

-

25% straight line

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Fixed asset investments

Fixed asset investments are shown at valuation. The valuation is market value, as provided by the investment brokers. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 September 2024

and 31 August 2025

618

DEPRECIATION

At 1 September 2024

and 31 August 2025

618

NET BOOK VALUE

At 31 August 2025

-

At 31 August 2024

-

5.	FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:

Totals

£

COST OR VALUATION

At 1 September 2024

134,295

Additions

210,233

Disposals

(25,042

)

Revaluations

11,534

At 31 August 2025

331,020

NET BOOK VALUE

At 31 August 2025

331,020

At 31 August 2024

134,295

The carrying value of the investments are market value, as provided by the Investment Brokers as at the balance sheet date.

The amount credited to profit and loss account during the year was £11,534 (2024: £453) in respect of revaluations.

6.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 August 2025 and 31 August 2024:

2025

2024

£

£

Mr J D Hayton and Mrs D J Hayton

Balance outstanding at start of year

197,546

118,172

Amounts advanced

95,145

184,552

Amounts repaid

(10,284

)

(105,178

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

282,407

197,546

Loans to directors were made on an interest free basis with no fixed repayment terms.

7.	RELATED PARTY DISCLOSURES

During the year the company paid dividends of £nil (2024: £36,000) to its directors and related family trusts.